Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2584-2596

  Bajwa, Amandeep ^a,b   Huang, Liping ^a,b   Ye, Hong ^a,b   Dondeti, Krishna ^a,b   Song, Steven ^a,b   Rosin, Diane L ^a,b   Lynch, Kevin R ^a   Lobo, Peter I ^a,b   Li, Li ^a,b   Okusa, Mark D ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 4; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELL MATURATION; CELL POLARITY; CELL PROTECTION; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME REGULATION; KIDNEY ISCHEMIA; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; REPERFUSION INJURY; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; CELL MOVEMENT; CELL POLARITY; CELLS, CULTURED; DENDRITIC CELLS; ISCHEMIA; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; NEUTROPHIL INFILTRATION; RECEPTORS, LYSOSPHINGOLIPID; REPERFUSION INJURY; TH1 CELLS; TH2 CELLS;

EID: 84865405053     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200999     Document Type: Article

References (90)

1. Bonventre, J. V., and L. Yang. 2011. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121: 4210-4221.
2. Grenz, A., J. D. Bauerle, J. H. Dalton, D. Ridyard, A. Badulak, E. Tak, E. N. McNamee, E. Clambey, R. Moldovan, G. Reyes, et al. 2012. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J. Clin. Invest. 122: 693-710.
3. Li, L., L. Huang, S. S. Sung, A. L. Vergis, D. L. Rosin, C. E. Rose, Jr., P. I. Lobo, and M. D. Okusa. 2008. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int. 74: 1526-1537.
4. Nelson, P. J. 2007. Renal ischemia-reperfusion injury: renal dendritic cells loudly sound the alarm. Kidney Int. 71: 604-605.
5. + interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 70: 591-596.
6. Li, L., and M. D. Okusa. 2010. Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin. Nephrol. 30: 268-277.
7. Li, L., L. Huang, S. S. Sung, P. I. Lobo, M. G. Brown, R. K. Gregg, V. H. Engelhard, and M. D. Okusa. 2007. NKT cell activation mediates neutrophil IFN-γ production and renal ischemia-reperfusion injury. J. Immunol. 178: 5899-5911.
8. Huang, Y., H. Rabb, and K. L. Womer. 2007. Ischemia-reperfusion and immediate T cell responses. Cell. Immunol. 248: 4-11.
9. + T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108: 1283-1290.
10. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
11. Dong, X., S. Swaminathan, L. A. Bachman, A. J. Croatt, K. A. Nath, and M. D. Griffin. 2007. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 71: 619-628.
12. Li, L., L. Huang, A. L. Vergis, H. Ye, A. Bajwa, V. Narayan, R. M. Strieter, D. L. Rosin, and M. D. Okusa. 2010. IL-17 produced by neutrophils regulates IFN-γ-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120: 331-342.
13. Leite-De-Moraes, M. C., A. Hameg, M. Pacilio, Y. Koezuka, M. Taniguchi, L. Van Kaer, E. Schneider, M. Dy, and A. Herbelin. 2001. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol. 166: 945-951.
14. Spiegel, S., and S. Milstien. 2002. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277: 25851-25854.
15. Spiegel, S., and R. Kolesnick. 2002. Sphingosine 1-phosphate as a therapeutic agent. Leukemia 16: 1596-1602.
16. Jo, S. K., A. Bajwa, A. S. Awad, K. R. Lynch, and M. D. Okusa. 2008. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int. 73: 1220-1230.
17. Takuwa, Y., N. Takuwa, and N. Sugimoto. 2002. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. J. Biochem. 131: 767-771.
18. Allende, M. L., J. L. Dreier, S. Mandala, and R. L. Proia. 2004. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279: 15396-15401.
19. Rosen, H., and E. J. Goetzl. 2005. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5: 560-570.
20. Idzko, M., E. Panther, S. Corinti, A. Morelli, D. Ferrari, Y. Herouy, S. Dichmann, M. Mockenhaupt, P. Gebicke-Haerter, F. Di Virgilio, et al. 2002. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 16: 625-627.
21. Bajwa, A., S. K. Jo, H. Ye, L. Huang, K. R. Dondeti, D. L. Rosin, V. H. Haase, T. L. Macdonald, K. R. Lynch, and M. D. Okusa. 2010. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J. Am. Soc. Nephrol. 21: 955-965.
22. Takuwa, N., S. Ohkura, S. Takashima, K. Ohtani, Y. Okamoto, T. Tanaka, K. Hirano, S. Usui, F. Wang, W. Du, et al. 2010. S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc. Res. 85: 484-493.
23. Li, C., X. Jiang, L. Yang, X. Liu, S. Yue, and L. Li. 2009. Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. Am. J. Pathol. 175: 1464-1472.
24. Li, C., Y. Kong, H. Wang, S. Wang, H. Yu, X. Liu, L. Yang, X. Jiang, L. Li, and L. Li. 2009. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J. Hepatol. 50: 1174-1183.
25. Singleton, P. A., L. Moreno-Vinasco, S. Sammani, S. L. Wanderling, J. Moss, and J. G. Garcia. 2007. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am. J. Respir. Cell Mol. Biol. 37: 222-231.
26. Tölle, M., B. Levkau, P. Keul, V. Brinkmann, G. Giebing, G. Schönfelder, M. Schäfers, K. von Wnuck Lipinski, J. Jankowski, V. Jankowski, et al. 2005. Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ. Res. 96: 913-920.
27. + endothelial cells in splenic marginal sinus organization. J. Exp. Med. 200: 1491-1501.
28. Niessen, F., F. Schaffner, C. Furlan-Freguia, R. Pawlinski, G. Bhattacharjee, J. Chun, C. K. Derian, P. Andrade-Gordon, H. Rosen, and W. Ruf. 2008. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452: 654-658.
29. Means, C. K., C. Y. Xiao, Z. Li, T. Zhang, J. H. Omens, I. Ishii, J. Chun, and J. H. Brown. 2007. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 292: H2944-H2951.
30. Theilmeier, G., C. Schmidt, J. Herrmann, P. Keul, M. Schäfers, I. Herrgott, J. Mersmann, J. Larmann, S. Hermann, J. Stypmann, et al. 2006. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114: 1403-1409.
31. Jo, S. K., A. Bajwa, H. Ye, A. L. Vergis, A. S. Awad, Y. Kharel, K. R. Lynch, and M. D. Okusa. 2009. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int. 75: 167-175.
32. Oz-Arslan, D., W. Rüscher, D. Myrtek, M. Ziemer, Y. Jin, B. B. Damaj, S. Sorichter, M. Idzko, J. Norgauer, and A. A. Maghazachi. 2006. IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids. J. Leukoc. Biol. 80: 287-297.
33. Day, Y. J., L. Huang, M. J. McDuffie, D. L. Rosin, H. Ye, J. F. Chen, M. A. Schwarzschild, J. S. Fink, J. Linden, and M. D. Okusa. 2003. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J. Clin. Invest. 112: 883-891.
34. Awad, A. S., H. Ye, L. Huang, L. Li, F. W. Foss, Jr., T. L. Macdonald, K. R. Lynch, and M. D. Okusa. 2006. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am. J. Physiol. Renal Physiol. 290: F1516-F1524.
35. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
36. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an alpha- galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188: 1521-1528.
37. Nieda, M., A. Nicol, Y. Koezuka, A. Kikuchi, T. Takahashi, H. Nakamura, H. Furukawa, T. Yabe, Y. Ishikawa, K. Tadokoro, and T. Juji. 1999. Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Hum. Immunol. 60: 10-19.
38. Sullivan, B. A., N. A. Nagarajan, G. Wingender, J. Wang, I. Scott, M. Tsuji, R. W. Franck, S. A. Porcelli, D. M. Zajonc, and M. Kronenberg. 2010. Mechanisms for glycolipid antigen-driven cytokine polarization by Va14i NKT cells. J. Immunol. 184: 141-153.
39. Liu, Y., R. D. Goff, D. Zhou, J. Mattner, B. A. Sullivan, A. Khurana, C. Cantu, III, E. V. Ravkov, C. C. Ibegbu, J. D. Altman, et al. 2006. A modified α-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 312: 34-39.
40. Zhou, D., J. Mattner, C. Cantu, III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingo-lipid recognition by NKT cells. Science 306: 1786-1789.
41. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, et al. 1998. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Va14 NKT cells. Proc. Natl. Acad. Sci. USA 95: 5690-5693.
42. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279.
43. Sköld, M., and S. M. Behar. 2003. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71: 5447-5455.
44. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
45. Eltzschig, H. K., and T. Eckle. 2011. Ischemia and reperfusion: from mechanism to translation. Nat. Med. 17: 1391-1401.
46. Day, Y. J., L. Huang, H. Ye, J. Linden, and M. D. Okusa. 2005. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am. J. Physiol. Renal Physiol. 288: F722-F731.
47. Berndt, B. E., M. Zhang, G. H. Chen, G. B. Huffnagle, and J. Y. Kao. 2007. The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J. Immunol. 179: 6255-6262.
48. Tadagavadi, R. K., and W. B. Reeves. 2010. Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J. Am. Soc. Nephrol. 21: 53-63.
49. Eltzschig, H. K., and P. Carmeliet. 2011. Hypoxia and inflammation. N. Engl. J. Med. 364: 656-665.
50. Morote-Garcia, J. C., P. Rosenberger, N. M. Nivillac, I. R. Coe, and H. K. Eltzschig. 2009. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 136: 607-618.
51. Ramesh, G., and W. B. Reeves. 2002. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110: 835-842.
52. +NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163: 93-101.
53. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. 1999. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189: 1121-1128.
54. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
55. Wu, D., G.W. Xing, M. A. Poles, A. Horowitz, Y. Kinjo, B. Sullivan, V. Bodmer- Narkevitch, O. Plettenburg, M. Kronenberg, M. Tsuji, et al. 2005. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. USA 102: 1351-1356.
56. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
57. Prussin, C., and B. Foster. 1997. TCR Vα24 and Vβ11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J. Immunol. 159: 5862-5870.
58. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1- specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15: 535-562.
59. + T cells and IFN-γ. J. Immunol. 176: 3108-3114.
60. Lappas, C. M., Y. J. Day, M. A. Marshall, V. H. Engelhard, and J. Linden. 2006. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J. Exp. Med. 203: 2639-2648.
61. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7: 1052-1056.
62. Laloux, V., L. Beaudoin, D. Jeske, C. Carnaud, and A. Lehuen. 2001. NK T cell-induced protection against diabetes in Vα14-Jα281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 166: 3749-3756.
63. Oh, S. J., and D. H. Chung. 2011. Invariant NKT cells producing IL-4 or IL-10, but not IFN-γ, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response. J. Immunol. 186: 6815-6821.
64. Yokota, N., M. Burne-Taney, L. Racusen, and H. Rabb. 2003. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 285: F319-F325.
65. Liu, M., P. Agreda, M. Crow, L. Racusen, and H. Rabb. 2009. Effects of delayed rapamycin treatment on renal fibrosis and inflammation in experimental ischemia reperfusion injury. Transplant. Proc. 41: 4065-4071.
66. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166: 6012-6018.
67. Ben-Shoshan, J., A. Afek, S. Maysel-Auslender, A. Barzelay, A. Rubinstein, G. Keren, and J. George. 2009. HIF-1α overexpression and experimental murine atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29: 665-670.
68. Park, S. W., M. Kim, K. M. Brown, V. D. D'Agati, and H. T. Lee. 2012. Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemiareperfusion injury. J. Am. Soc. Nephrol. 23: 266-280.
69. Maeda, Y., H. Matsuyuki, K. Shimano, H. Kataoka, K. Sugahara, and K. Chiba. 2007. Migration of CD4 T cells and dendritic cells toward sphingosine 1- phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. J. Immunol. 178: 3437-3446.
70. Rivera, J., R. L. Proia, and A. Olivera. 2008. The alliance of sphingosine-1- phosphate and its receptors in immunity. Nat. Rev. Immunol. 8: 753-763.
71. Lappin, M. B., J. M. Weiss, V. Delattre, B. Mai, H. Dittmar, C. Maier, K. Manke, S. Grabbe, S. Martin, and J. C. Simon. 1999. Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology 98: 181-188.
72. Ouyang, J., C. Fan, D. Wen, J. Hou, Y. Du, Y. Wang, and G. Shi. 2010. Donor antigen-loaded IKK2dn gene-modified dendritic cells prolong allograft survival. Scand. J. Immunol. 71: 336-344.
73. Tiao, M. M., L. Lu, R. Tao, L. Wang, J. J. Fung, and S. Qian. 2005. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-κB activity. Ann. Surg. 241: 497-505.
74. Sun, W., Q. Wang, L. Zhang, Y. Liu, M. Zhang, C. Wang, J. Wang, and X. Cao. 2003. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin. Transplantation 76: 1351-1359.
75. Tiao, M. M., L. Lu, R. Tao, J. Harnaha, J. J. Fung, L. T. Huang, and S. Qian. 2004. Application of recipient-derived dendritic cells to induce donor-specific Tcell hyporesponsiveness. Transplant. Proc. 36: 1592-1594.
76. Tao, R., L. Wang, C. H. Chen, S. H. Wang, R. A. Demarco, M. T. Lotze, N. L. Thai, J. J. Fung, L. Lu, and S. Qian. 2006. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus. J. Heart Lung Transplant. 25: 310-319.
77. Bonham, C. A., L. Peng, X. Liang, Z. Chen, L. Wang, L. Ma, H. Hackstein, P. D. Robbins, A. W. Thomson, J. J. Fung, et al. 2002. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J. Immunol. 169: 3382-3391.
78. Morelli, A. E. 2006. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am. J. Transplant. 6: 254-261.
79. Wang, Z., A. T. Larregina, W. J. Shufesky, M. J. Perone, A. Montecalvo, A. F. Zahorchak, A. W. Thomson, and A. E. Morelli. 2006. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am. J. Transplant. 6: 1297-1311.
80. Hackstein, H., and A. W. Thomson. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24-34.
81. Goldberg, L. C., J. A. Bradley, J. Connolly, P. J. Friend, D. B. Oliveira, N. R. Parrott, R. S. Rodger, D. Taube, and M. G. Thick. 1995. Anti-CD45 monoclonal antibody perfusion of human renal allografts prior to transplantation: a safety and immunohistological study. CD45 Study Group. Transplantation 59: 1285-1293.
82. Green, E. A., E. E. Eynon, and R. A. Flavell. 1998. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9: 733-743.
83. Mehling, A., K. Loser, G. Varga, D. Metze, T. A. Luger, T. Schwarz, S. Grabbe, and S. Beissert. 2001. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194: 615-628.
84. Daemen, M. A., B. de Vries, and W. A. Buurman. 2002. Apoptosis and inflammation in renal reperfusion injury. Transplantation 73: 1693-1700.
85. Barkett, M., and T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18: 6910-6924.
86. Li, Q., and I. M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734.
87. Rescigno, M., M. Martino, C. L. Sutherland, M. R. Gold, and P. Ricciardi- Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188: 2175-2180.
88. Ishiyama, T., S. Dharmarajan, M. Hayama, H. Moriya, K. Grapperhaus, and G. A. Patterson. 2005. Inhibition of nuclear factor κB by IκB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J. Thorac. Cardiovasc. Surg. 130: 194-201.
89. Cao, C. C., X. Q. Ding, Z. L. Ou, C. F. Liu, P. Li, L. Wang, and C. F. Zhu. 2004. In vivo transfection of NF-κB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int. 65: 834-845.
90. Salomone, S., and C. Waeber. 2011. Selectivity and specificity of sphingosine-1- phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects. Front Pharmacol 2: 9.